Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v2.3.0.15
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Condensed Consolidated Statements of Operations [Abstract]        
Revenues $ 1,140,768 $ 800,743 $ 3,487,824 $ 2,195,812
Cost of goods sold 1,130,332 160,772 1,893,412 536,185
Gross profit 10,436 639,971 1,594,412 1,659,627
Costs and expenses:        
Sales and marketing 499,118 320,850 1,318,007 975,839
Research and development 76,982 36,169 117,149 75,452
Salaries, wages and related costs 1,189,289 771,518 2,941,530 2,522,419
General and administrative 827,054 336,038 2,005,740 910,585
Depreciation and amortization 44,427 54,220 191,589 208,502
Total costs and expenses 2,636,870 1,518,795 6,574,015 4,692,797
Loss from operations (2,626,434) (878,824) (4,979,603) (3,033,170)
Other income (expense):        
Interest expense (318,110) (193,251) (954,360) (516,266)
Interest expense - deferred financing costs (169,007) (10,473) (1,200,413) (134,808)
Gain from termination of distribution agreement       1,119,094
Change in fair value of warrant liability   139,157 62,305 (77,695)
Other income (expense) 381 28 (10,163) 36
Total other income (expense) (486,736) (64,539) (2,102,631) 390,361
Net loss (3,113,170) (943,363) (7,082,234) (2,642,809)
Preferred Stock dividends (assumes all paid) (329,832) (308,944) (1,028,351) (1,243,992)
Net loss available to common shareholders $ (3,443,002) $ (1,252,307) $ (8,110,585) $ (3,886,801)
Weighted Average Common Shares outstanding - basic and diluted 1,324,967 1,191,000 1,248,798 715,198
Loss Per Common share - basic and diluted $ (2.60) $ (1.05) $ (6.49) $ (5.43)